| Type | Title | Date Released | |
|---|---|---|---|
4 | Payton Lori (Reporting) | ||
4 | Alford Rachael (Reporting) | ||
4 | Frey Rebecca (Reporting) | ||
4 | Ryder Steven (Reporting) | ||
4 | Zeronda Tyler (Reporting) | ||
SCHEDULE 13G | Bellevue Group AG (Filed by) | ||
SCHEDULE 13G | Invus Global Management, LLC (Filed by) | ||
8-K | Yarrow Bioscience Announces Pricing and Full Exercise of Option for $161.8 Million Common Stock Offering | ||
424B5 | REGISTERED OFFERING | ||
424B5 | PENDING FIXED PRICE OFFERING | ||
8-K | Yarrow Bioscience Overview of YB-101 Development for Graves' Disease and Thyroid Eye Disease | ||
EFFECT | Form EFFECT |
